These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 16135499)

  • 1. Sequential or concurrent tamoxifen and radiotherapy: to see or not to see--that is the question!
    Bentzen SM; Yarnold JR
    J Clin Oncol; 2005 Sep; 23(25):6266-7; author reply 6267. PubMed ID: 16135499
    [No Abstract]   [Full Text] [Related]  

  • 2. Radiation therapy and tamoxifen: concurrent or sequential? That is the question.
    Whelan T; Levine M
    J Clin Oncol; 2005 Jan; 23(1):1-4. PubMed ID: 15545667
    [No Abstract]   [Full Text] [Related]  

  • 3. [Is low-dose tamoxifen an effective therapy for breast carcinoma in situ?].
    Ivanova OA; Zhil'tsova EK; Barash NIu; Ivanov VG; Ermachenkova AM
    Vopr Onkol; 2011; 57(5):601-3. PubMed ID: 22238929
    [No Abstract]   [Full Text] [Related]  

  • 4. Concurrent versus sequential radiotherapy and tamoxifen in breast cancer - The CONSET trial is launched.
    Munshi A; Gupta D
    Acta Oncol; 2011 Jan; 50(1):154-5. PubMed ID: 20843175
    [No Abstract]   [Full Text] [Related]  

  • 5. [Radiotherapy and tamoxifen facilitate breast-preserving treatment of ductal carcinoma in situ of the breast].
    Sautter-Bihl ML
    Strahlenther Onkol; 1999 Dec; 175(12):620-1. PubMed ID: 10633790
    [No Abstract]   [Full Text] [Related]  

  • 6. Neoadjuvant endocrine therapy for breast cancer: more questions than answers.
    Ellis MJ
    J Clin Oncol; 2005 Aug; 23(22):4842-4. PubMed ID: 15998901
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of tamoxifen in pT1a-pT1b, pN0 breast cancer.
    Livi L; Saieva C; Paiar F; Simontacchi G; Galardi A; De Luca Cardillo C; Mangoni M; Paoletti L; Ponticelli P; Biti GP
    Eur J Surg Oncol; 2007 Apr; 33(3):271-5. PubMed ID: 16831531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of adjuvant tamoxifen therapy among older women with early stage breast cancer.
    Owusu C; Lash TL; Silliman RA
    Breast J; 2007; 13(4):374-82. PubMed ID: 17593042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [On the interaction of adjuvant radiotherapy and tamoxifen treatment for breast cancer].
    Hoeller U; Borgmann K; Feyer P; Souchon R;
    Strahlenther Onkol; 2007 Oct; 183(10):535-44. PubMed ID: 17896084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiation therapy and tamoxifen: concurrent or sequential? It's no longer the question!
    Azria D; Pelegrin A; Dubois JB; Mirimanoff RO; Ozsahin M
    J Clin Oncol; 2005 Jun; 23(18):4239-41; author reply 4241-2. PubMed ID: 15961779
    [No Abstract]   [Full Text] [Related]  

  • 11. Lumpectomy and tamoxifen alone without additional radiotherapy for women 70 years of age or older with estrogen receptor-positive breast cancer.
    Ferretti G; Mandalà M; Bria E; Carlini P; Papaldo P; Fabi A; Felici A; Cognetti F
    Breast Cancer Res Treat; 2005 Apr; 90(3):319. PubMed ID: 15830147
    [No Abstract]   [Full Text] [Related]  

  • 12. What is the impact of tamoxifen on radiation-induced fibrosis in patients receiving breast-conserving therapy.
    Koc M
    J Clin Oncol; 2007 Dec; 25(36):5841; author reply 5844-5. PubMed ID: 18089889
    [No Abstract]   [Full Text] [Related]  

  • 13. Neoadjuvant endocrine therapy in breast cancer.
    Abrial C; Mouret-Reynier MA; Curé H; Feillel V; Leheurteur M; Lemery S; Le Bouëdec G; Durando X; Dauplat J; Chollet P
    Breast; 2006 Feb; 15(1):9-19. PubMed ID: 16230013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overview of randomized trials of systemic adjuvant therapy.
    Ravdin PM
    Cancer Treat Res; 2000; 103():157-81. PubMed ID: 10948446
    [No Abstract]   [Full Text] [Related]  

  • 15. [For postmenopausal women with hormone-dependent tumors. Aromatase inhibitors are the new gold standard].
    Jonat W
    MMW Fortschr Med; 2006 Mar; 148(12):10. PubMed ID: 16625996
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of adjuvant systemic treatment on cosmetic outcome and late normal-tissue reactions after breast conservation.
    Johansen J; Overgaard J; Overgaard M
    Acta Oncol; 2007; 46(4):525-33. PubMed ID: 17497320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of tumor progesterone receptor status on optimal adjuvant endocrine therapy for postmenopausal patients with early-stage breast cancer: a decision analysis.
    Punglia RS; Kuntz KM; Winer EP; Weeks JC; Burstein HJ
    Cancer; 2006 Jun; 106(12):2576-82. PubMed ID: 16703595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is radiation necessary for older women with breast cancer? Once the tumor is removed, tamoxifen by itself is effective, but for younger women it's a very different story.
    Health News; 2004 Dec; 10(12):6-7. PubMed ID: 15645562
    [No Abstract]   [Full Text] [Related]  

  • 19. A candidate molecular signature associated with tamoxifen failure in primary breast cancer.
    Vendrell JA; Robertson KE; Ravel P; Bray SE; Bajard A; Purdie CA; Nguyen C; Hadad SM; Bieche I; Chabaud S; Bachelot T; Thompson AM; Cohen PA
    Breast Cancer Res; 2008; 10(5):R88. PubMed ID: 18928543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissemination of adjuvant multiagent chemotherapy and tamoxifen for breast cancer in the United States using estrogen receptor information: 1975-1999.
    Mariotto AB; Feuer EJ; Harlan LC; Abrams J
    J Natl Cancer Inst Monogr; 2006; (36):7-15. PubMed ID: 17032888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.